Toggle Accessibility Statement Skip to Main Content ARSP 2025 Annual Report Data Summary is now available for download The Antimicrobial Resistance Surveillance Program (ARSP) presents national estimates and trends on the antimicrobial resistance of clinically significant aerobic… Application for ARSP Accreditation 2026-2027 Cycle is now open from June 01, 2026 – August 31, 2026 The ARSP Accreditation is granted to aerobic bacteriology laboratories that maintains suitable performance standards. The bacteriology laboratory applying for… ARSP 2024 Annual Report Data Summary is now available for download The Antimicrobial Resistance Surveillance Program (ARSP) presents national estimates and trends on the antimicrobial resistance of clinically significant aerobic… Application for ARSP Accreditation 2025 Cycle is now open from June 02, 2025 – August 29, 2025 The ARSP Accreditation is granted to aerobic bacteriology laboratories that maintains suitable performance standards. The bacteriology laboratory applying for… Revised Citizen’s Charter and Affidavit of Undertaking for ARSP Accreditation (June 2 – August 29, 2025) Requirements and procedure for application to the Antimicrobial Resistance Surveillance Program (ARSP) Accreditation of aerobic bacteriology laboratories. Click “Download”… Latest Publication Access to New Antibacterials in 10 Asian Countries: an Asian Network for Surveillance of Resistant Pathogens study Summary: This article examines access to newly developed antibacterial medicines across ten Asian countries through a study conducted by… Detection of a Serratia sarumanii outbreak in neonatal intensive care units using SaTScan and whole genome sequencing, Philippines, 2022

This study aimed to demonstrate the benefits of using SaTScan (Boston, MA, USA), a cluster-detection software programme, and whole… High in vitro activity of the novel antimicrobial gepotidacin against Neisseria gonorrhoeae isolates in eight WHO – EGASP countries in three WHO regions, 2021–24 The ARSP EGASP Study Group contributed to a new multi-country WHO EGASP analysis evaluating gepotidacin, a first-in-class oral antimicrobial… High susceptibility to the novel antimicrobial zoliflodacin among Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024 The ARSP EGASP Study Group contributed to a recent multi-country study evaluating zoliflodacin, a new drug candidate for gonorrhea…. Ciprofloxacin resistance in Klebsiella pneumoniae: phenotype prediction from genotype and global distribution of resistance determinants The Antimicrobial Resistance Surveillance Reference Laboratory (ARSRL) researchers joined the international KlebNET-GSP consortium in a new preprint that develops… ARSP 2025 Annual Report Data Summary is now available for download The Antimicrobial Resistance Surveillance Program (ARSP) presents national estimates and trends on the antimicrobial resistance of clinically significant aerobic… WHO WPRO Publishes Practical Manual on Clinical Diagnostic Stewardship The WHO Western Pacific Regional Office has published , a resource that supports improved diagnosis, treatment, prevention, and control… Global research agenda for antimicrobial resistance in human health Antimicrobial resistance (AMR) continues to pose a growing threat to global health, demanding coordinated action and evidence-based solutions. In… Diversity, functional classification and genotyping of SHV β-lactamases in Klebsiella pneumoniae Abstract Interpreting the phenotypes of blaSHV alleles in Klebsiella pneumoniae genomes is complex. Whilst all strains are expected to…